Gross Profit Analysis: Comparing AbbVie Inc. and Walgreens Boots Alliance, Inc.

Comparative Gross Profit Trends: AbbVie vs. Walgreens

__timestampAbbVie Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 20141553400000021569000000
Thursday, January 1, 20151835900000026753000000
Friday, January 1, 20161980500000029874000000
Sunday, January 1, 20172117600000029162000000
Monday, January 1, 20182503500000030792000000
Tuesday, January 1, 20192582700000028159000000
Wednesday, January 1, 20203041700000026077000000
Friday, January 1, 20213875100000028067000000
Saturday, January 1, 20224064000000028266000000
Sunday, January 1, 20233390300000027072000000
Monday, January 1, 20243943000000026524000000
Loading chart...

Cracking the code

Gross Profit Trends: AbbVie Inc. vs. Walgreens Boots Alliance, Inc.

In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding financial performance is crucial. From 2014 to 2023, AbbVie Inc. and Walgreens Boots Alliance, Inc. have shown distinct trajectories in their gross profit margins. AbbVie Inc. experienced a remarkable growth, with its gross profit increasing by approximately 118% from 2014 to 2022, peaking in 2022. However, 2023 saw a slight dip, indicating potential market challenges or strategic shifts. In contrast, Walgreens Boots Alliance, Inc. maintained a relatively stable gross profit, with minor fluctuations, peaking in 2018. This stability suggests a consistent market presence, though it faced a slight decline in 2023. The absence of data for AbbVie in 2024 highlights the need for updated insights. These trends underscore the dynamic nature of these industries and the importance of strategic adaptability.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025